Sharpline Broadcast Reports FY26 PAT of Rs 3.33 Crore; Expands Portfolio

MEDIA-AND-ENTERTAINMENT
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Sharpline Broadcast Reports FY26 PAT of Rs 3.33 Crore; Expands Portfolio

Sharpline Broadcast Limited reported a robust FY26, with standalone profit after tax climbing to Rs 3.33 crore from Rs 1.17 crore in the previous year. The company diversified into healthcare via the acquisition of Unayur Marketing and strengthened its media arm through Broad Cast Equipment (India). While debt was reduced via a Rs 16.60 crore preferential issue, the company reported prior governance non-compliance issues that have since been rectified.

Sharpline Broadcast Reports Strong FY26 Financials

Revenue grew to Rs 66.63 crore from Rs 41.44 crore; PAT rose to Rs 3.33 crore from Rs 1.17 crore.

Reader Takeaway: Strong revenue growth and debt reduction through share issuance signal expansion, though governance history requires monitoring.

What just happened

Sharpline Broadcast Limited released its Annual Report for FY 2025-26, reporting significant operational and financial growth. The company successfully increased its standalone Profit After Tax (PAT) to Rs 3.33 crore compared to Rs 1.17 crore in FY 2024-25. Total income for the year stood at Rs 68.86 crore.

Why this matters

The company has aggressively diversified its portfolio by acquiring two subsidiaries. It entered the healthcare sector by purchasing a 99.51% stake in Unayur Marketing Private Limited and bolstered its media capabilities with a 62.36% stake in Broad Cast Equipment (India) Private Limited. Furthermore, the company settled outstanding loan liabilities by issuing 1,18,57,140 equity shares via a preferential allotment at Rs 14 per share, totaling Rs 16.60 crore.

Governance and Auditor Observations

The company's Secretarial Audit Report for FY 2025-26 contained a modified opinion. The auditor noted temporary lapses in appointing a Company Secretary and maintaining proper board committee composition. Management confirmed these issues were rectified as of March 2026.

What changes now

The company has increased its authorized share capital from Rs 27.50 crore to Rs 35.00 crore to support future growth. Management has decided not to declare a dividend, choosing instead to retain earnings to fund ongoing financial requirements and integration of the new subsidiaries.

What to track next

Investors should monitor the revenue contribution from the newly acquired healthcare arm and the operational synergies resulting from the media subsidiary acquisition in the upcoming quarters.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.